Getting back to remdesivir, let's hope the unblinding brings good news.
I haven't seen anything on the results of the remdesivir trial that completed yesterday. The lack of news is disappointing, but in some ways promising. If the trial showed great positive results, they would have halted the trial early, or at least provided some data yesterday. On the other hand, if the trial was an obvious failure, that would have come out yesterday. My guess is the data showed mixed results, and they are now doing a deep dive to see if they can find promising segments, for example, positive results for patients before or after a point in time.